Five Prime Therapeutics Inc
Combination Therapy for Cancer
Last updated:
Abstract:
Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with one or more immune stimulating agents are provided.
Status:
Application
Type:
Utility
Filling date:
10 Feb 2020
Issue date:
30 Jul 2020